A strategic thought partner for your AI journey.
With a depth of expertise in supporting critical decision making, we take a people-centric approach to solving your challenges, built on bringing together solutions across three pillars:
1. Strategic expertise in the life sciences
2. Clinical and scientific understanding
3. Analytics and AI capabilities and solutions
Our human expertise has always allowed us to deliver exceptional and innovative outcomes, and it always will. But today, we’ve embraced the power of AI to complement what our teams have to offer to create an even deeper impact for clients. With a thoughtful, experimental approach to this technology and its limitations, we’re strategically unlocking the tremendous value of AI to support our clients in identifying and prioritizing use cases through the intelligence of our people.
AI enables us to:
A data platform that combines human expertise and AI-driven insights, so our consultants can support you with faster strategic decision making when bringing your drugs to market.
See how we’re bringing together the intelligence of our people and the intelligence behind AI to help clients make strategic, confident decisions and develop innovative solutions that maximize patient outcomes.
Read how our client aims to locate organizations advancing AI algorithms for rare disease detection.
Assessing the opportunity and investment of AI and biomarker diagnostic solutions.
Putnam established technical feasibility for use of Gen AI to create Plain Language Summaries (PLS).
Hear what our former CEO, Remco op den Kelder has to share on AI – Putnam’s approach, client challenges, 2024 predictions, and more.
As I take a moment to reflect on the past two-plus years of our AI journey and consider the predictions I made for 2024, it’s clear that many...
We explore two instances where our consulting teams used AssetNav to help clients prioritize promising BD&L opportunities in oncology.
ClarityNav, harnessed by our consultants, is redefining how medical insights are gathered, analyzed, and applied.
Personalized medicine is revolutionizing the field of oncology, and gastrointestinal (GI) cancers are at the forefront of this exciting development.
Across Inizio Advisory, we’re helping you navigate with certainty through connected capabilities in market research, consulting, and brand measurement, combined with our AI powered technology platforms and data-driven insights.